Zhejiang Yongtai Technology

What Zhejiang Yongtai Technology does

Zhejiang Yongtai Technology Co., Ltd. is a Chinese fluorine fine chemicals manufacturer headquartered in Linhai, Zhejiang Province, that produces specialty fluorinated intermediates across three end markets: pharmaceuticals, crop protection, and advanced materials. Founded in 1999 initially for dye intermediates, the company has shifted its core franchise to fluorobenzene chemistry and was listed on the Shenzhen Stock Exchange under stock code 002326 on December 22, 2009. The company operates more than 700,000 square meters of production capacity across multiple Chinese provinces (Zhejiang, Jiangsu, Shandong, Shanghai, Fujian, Inner Mongolia, Guangdong) supported by 3,000+ employees and roughly 17 subsidiaries spanning pharmaceutical APIs, chiral intermediates, lithium battery materials, new energy materials, and overseas chemical distribution. Its Linhai API facility holds US FDA Establishment Inspection Report clearance (August 2017), China GMP certification (March 2017), and CEP certification (April 2017), plus ISO9001, ISO14001, and OHSAS18001 certifications and a CNAS-certified security laboratory.

The company operates four revenue streams: pharmaceutical intermediates and APIs (Pharma division), agrochemical intermediates and CMO services (Crop Science division), advanced materials including fluorinated liquid crystals, lithium battery materials, fluoride liquids, and photoresist for color filters (Materials division), and contract manufacturing for global pharmaceutical and chemical companies. Pricing is quote-based B2B with no public list, and sales are organized by division. Over 80% of production is exported to the US, Europe, Japan, and India, serving named global pharmaceutical MNCs (Merck, Pfizer, Gilead) and agrochemical giants (BASF, Bayer, Sumitomo, Syngenta). The 2015 acquisition of Shanghai Nonghui (上海淦辉) gave Yongtai a global pesticide distribution network spanning 60+ countries with approximately 500 overseas pesticide registration certificates and roughly 1,800 pesticide product registration filings, supported by international subsidiaries in the US (Cranbury, NJ), Costa Rica, Vietnam, Nigeria, Indonesia, Philippines, and Pakistan. The company holds proprietary patents on the manufacturing processes for key intermediates of Sitagliptin (Merck's Januvia, ~$4 billion annual sales) and Sofosbuvir (Gilead's hepatitis C drug) and is the largest global supplier of both.

Disclosed financial performance includes revenue of 6.34 billion CNY in 2022 declining to 4.13 billion CNY in 2023 (a 35% contraction) with Q1 2024 revenue of 821.7 million CNY and subsequent recovery toward roughly $746M USD in 2025. The vertical integration spans intermediates-to-APIs-to-formulations in pharmaceuticals, and the company has pursued new growth through lithium battery materials (5,000-ton-per-year additive project announced at Inner Mongolia Yongtai Chemical in June 2025) and import-substitution photoresist materials for color filters in flat panel displays. Recent strategic actions during 2025-2026 include a Sitagliptin and Levodopa capacity expansion at Zhejiang Yongtai Shouxin (environmental acceptance August 2025) and termination of a planned share issuance to acquire a 25% equity stake in subsidiary Shaowu Yongtai Hi-tech Materials from Contemporary Amperex Technology Co. (CATL) in February 2026.

Name

Zhejiang Yongtai Technology

Legal name

浙江永太科技股份有限公司

Website

https://yongtaitech.com

Company type

Public

Founded year

1999

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Zhejiang Yongtai Technology is a Chinese fluorine fine chemicals manufacturer producing patented pharmaceutical intermediates (Sitagliptin, Sofosbuvir), agrochemical intermediates, fluorinated advanced materials, and contract manufacturing services for global pharma, crop science, and electronics customers across 60+ countries.

Ownership category

akta.pro rank

Product category

Specialty Chemicals

NAICS

Chemical Manufacturing (325), Other Chemical Product and Preparation Manufacturing (3259)

SIC

Industrial Organic Chemicals (2860), Chemicals & Allied Products (2800), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Electronic & High-Purity Specialty Chemicals (IMAEABAD)

akta.pro secondary industry

Battery & Energy Storage High-Purity Chemicals (Electrolyte salts/solvents, additives) (IMAEAKAM)

Keywords

• Fluorinated fine chemicals
• Pharmaceutical intermediates
• Crop protection chemicals
• Liquid crystal materials
• Lithium battery materials

Headquarters

HQ city

Linhai

HQ country

China

HQ region

Asia

Offices18 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Infrastructure

Revenue model

1. Pharmaceutical Intermediates and APIs: Manufacture and sale of fluorinated pharmaceutical intermediates and active pharmaceutical ingredients (APIs) serving global pharmaceutical MNCs. Products include Sitagliptin intermediates (for Januvia, ~$4B annual sales), Sofosbuvir intermediates (for Gilead's hepatitis C drug), and intermediates for cardiovascular, anti-viral, quinolone antibiotics, and CNS drugs. Revenue from pharmaceutical segment is a major contributor to overall sales.
2. Pesticide/Crop Science Intermediates and CMO Services: Manufacture and export of fluorinated pesticide intermediates, herbicides, and fungicides. Provides custom manufacturing (CMO) services to global pesticide giants at thousand-ton scale. Through Shanghai Nonghui acquisition, established a global distribution network covering 60+ countries with ~500 overseas pesticide registration certificates. Over 80% of products exported to Europe, US, Japan markets.
3. Advanced Materials (Liquid Crystal, Lithium Battery, Fluoride Liquid): Sale of fluorinated liquid crystal materials to global LCD manufacturers, lithium battery materials for new energy applications, and fluoride liquid materials. The company has become a major supplier to global LCD giants and is developing new energy materials leveraging fluorochemistry expertise.
4. Contract Manufacturing Organization (CMO/CDMO): Provides contract manufacturing services to global innovative pharmaceutical and chemical companies. Yongtai assigns dedicated project managers to follow each contract from quotation through shipment, pursuing rapidity, agility, and transparency as the foundation for building trusted cooperative relationships.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Zhejiang Yongtai Technology manufactures and sells fluorinated fine chemical products including pharmaceutical intermediates, crop protection chemicals, liquid crystal intermediates, and lithium battery electrolyte materials. The company operates a vertically integrated production chain anchored by the world's largest fluorobenzene product line and offers custom synthesis and contract manufacturing (CMO/CDMO) services to global pharmaceutical and agrochemical customers.

Product overview

Zhejiang Yongtai Technology operates as a fluorinated fine chemical manufacturer with four main business segments: Pharmaceuticals (含氟医药), Plant Protection/Crop Science (植物保护), Advanced Materials (新型材料), and Contract Manufacturing Services (CMO). The company has built a vertical integration strategy from intermediates to APIs to formulations in pharmaceuticals. Their fluorinated pharmaceutical intermediates serve global pharmaceutical giants including Merck, Pfizer, and Gilead, with proprietary positions in Sitagliptin and Sofosbuvir key intermediates. In agriculture, they provide custom manufacturing for herbicides and fungicides to major agrochemical companies worldwide. The Advanced Materials segment covers liquid crystal materials for displays, lithium battery materials for new energy applications, and fluoride liquid materials. The company operates multiple production sites across China and maintains US FDA, China GMP, and EU GMP certifications at their pharmaceutical manufacturing facilities.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Intermediates
• Crop Protection Chemicals
• Liquid Crystal Materials
• Lithium Battery Materials
• CMO/CDMO Services

Quantifiable outcome

• Yongtai is the largest global supplier of Sitagliptin key intermediates (for Januvia, ~$4B annual sales)
• +3 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

One partnership is on record.

• Contemporary Amperex Technology Co., Ltd. (CATL)minorStrategic or Co-development Partner · 13 February 2026Zhejiang Yongtai had planned to acquire a 25% equity stake in Shaowu Yongtai Hi-tech Material Co., Ltd. from CATL. The planned share issuance was suspended in February 2026 and subsequently terminated on February 13, 2026, citing failure of all parties to reach consensus on the transaction plan. Trading of Yongtai A-shares resumed on February 24, 2026. The termination will not adversely impact the company's business development, operations, or financial position as the transaction remained in planning stage with no formal agreements signed.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Zhejiang Juhua Co., Ltd. One of China's largest fluorinated chemicals producers (HF, refrigerants, fluoropolymers, fluorinated intermediates). Directly comparable to Yongtai in fluorinated fine chemistry platform scope, scale and end-market coverage across domestic and export markets.
• Do-Fluoride Chemicals Co., Ltd. A leading Chinese supplier of inorganic fluorides, fluorinated electrolyte salts (LiPF6) and battery materials — closely overlaps with Yongtai's fluorochemical + battery additive strategy and serves many of the same downstream end-markets including lithium-ion battery customers.
• Shanghai 3F New Materials Co., Ltd. A fluorinated chemicals producer spanning refrigerants, fluoropolymers and fluorinated intermediates. Comparable to Yongtai in Chinese fluorochemical manufacturing footprint, although its refrigerant focus differs from Yongtai's pharma/agro bias.

Others

• Sumitomo Chemical Co., Ltd. A Japanese diversified chemical and agrochemical giant that is both a customer and a partial peer for Yongtai's fluorinated pesticide intermediates and crop science CMO business, given their shared position in agro/pesticide supply chains.
• Morita Chemical Industries Co., Ltd. A Japanese producer of inorganic fluorides and fluorinated specialty chemicals serving electronics, agro and pharma applications. Comparable to Yongtai's high-purity fluorinated intermediates and Japanese customer overlap (e.g., Sumitomo Chemical).

Broad incumbents

• Honeywell International Inc. A global industrial conglomerate with significant fluorochemicals business ( refrigerants, blowing agents, fluorinated specialties). Comparable as a broad incumbent in fluorinated chemistry, even though Honeywell's portfolio is much larger and more diversified than Yongtai's specialty intermediates focus.
• Daikin Industries, Ltd. A global Japanese fluorochemicals leader spanning refrigerants, fluoropolymers and specialty fluorinated chemicals. As a broader incumbent, Daikin's fluorinated specialty portfolio overlaps with Yongtai's high-purity materials work despite operating at much larger scale and breadth.

Emerging players

• Asymchem Laboratories (Tianjin) Co., Ltd. A leading Chinese CDMO providing custom synthesis and API manufacturing services to global pharma MNCs. Comparable to Yongtai's CMO/CDMO offerings that supply global pharma intermediates and APIs, although with broader small-molecule therapeutic scope.
• Pharmaron (Beijing) Co., Ltd. A China-origin, global-scale CRO/CDMO serving pharmaceutical and biotech customers. Comparable to Yongtai on pharma intermediate and custom manufacturing services, though with stronger biologic services and Western lab footprint.
• Capchem Technology Co., Ltd. A leading Chinese electrolyte supplier for lithium-ion batteries, with overlapping fluorine chemistry know-how. Comparable to Yongtai's lithium battery materials and additive strategy at the battery electrolyte interface.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/zhejiang-yongtai-technology-co.-ltd

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries17 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zhejiang Yongtai Technology